Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial
- 14 July 2009
- journal article
- research article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 10 (8), 785-793
- https://doi.org/10.1016/s1470-2045(09)70172-x
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Cisplatin-Based Three Drugs Combination (NIP) as Induction and Adjuvant Treatment in Locally Advanced Non-small Cell Lung Cancer: Final ResultsJournal of Thoracic Oncology, 2008
- Definitive Chemoradiation for the Treatment of Locally Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2007
- A Systematic Review and Meta-analysis of the Literature: Chemotherapy and Surgery versus Surgery Alone in Non-small Cell Lung CancerJournal of Thoracic Oncology, 2006
- 2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice GuidelineJournal of Clinical Oncology, 2006
- Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II studyBritish Journal of Cancer, 2006
- Comparative prognostic features of stage IIIAN2 and IIIB non-small-cell lung cancer patients treated with surgery after induction therapyEuropean Journal of Cardio-Thoracic Surgery, 2005
- Surgery after multimodality treatment for non-small-cell lung cancerLung Cancer, 2004
- Combined modality trials of the Cancer and Leukemia Group B in stage III non-small-cell lung cancer: analysis of factors influencing survival and toxicityAnnals of Oncology, 2004
- Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung CancerNew England Journal of Medicine, 1992
- The Will Rogers PhenomenonNew England Journal of Medicine, 1985